JPH04108393A - Production of oleic acid-containing lipid and microorganism - Google Patents
Production of oleic acid-containing lipid and microorganismInfo
- Publication number
- JPH04108393A JPH04108393A JP2224434A JP22443490A JPH04108393A JP H04108393 A JPH04108393 A JP H04108393A JP 2224434 A JP2224434 A JP 2224434A JP 22443490 A JP22443490 A JP 22443490A JP H04108393 A JPH04108393 A JP H04108393A
- Authority
- JP
- Japan
- Prior art keywords
- oleic acid
- containing lipid
- producing
- lipid
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 title claims abstract description 57
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 title claims abstract description 57
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 title claims abstract description 57
- 239000005642 Oleic acid Substances 0.000 title claims abstract description 57
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 title claims abstract description 57
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 title claims abstract description 57
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 title claims abstract description 49
- 150000002632 lipids Chemical class 0.000 title claims abstract description 32
- 244000005700 microbiome Species 0.000 title claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- -1 phospholipid oleate Chemical class 0.000 claims abstract description 12
- 238000012258 culturing Methods 0.000 claims abstract description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 8
- 239000001963 growth medium Substances 0.000 abstract description 4
- 238000005273 aeration Methods 0.000 abstract description 2
- 238000001556 precipitation Methods 0.000 abstract description 2
- 239000007787 solid Substances 0.000 abstract description 2
- 229940049964 oleate Drugs 0.000 abstract 3
- 238000009630 liquid culture Methods 0.000 abstract 2
- 238000012834 spinner culture method Methods 0.000 abstract 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- 239000002609 medium Substances 0.000 description 18
- 235000014113 dietary fatty acids Nutrition 0.000 description 17
- 229930195729 fatty acid Natural products 0.000 description 17
- 239000000194 fatty acid Substances 0.000 description 17
- 230000001580 bacterial effect Effects 0.000 description 16
- 150000004665 fatty acids Chemical class 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 239000013535 sea water Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000013372 meat Nutrition 0.000 description 7
- 150000003904 phospholipids Chemical class 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 125000004185 ester group Chemical group 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N ornithyl group Chemical group N[C@@H](CCCN)C(=O)O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明はオレイン酸含有jiii質、オレイン酸及び/
又はオレイン酸リン脂質の製造方法並びにそれを製造す
るための新種微生物二二関する。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention provides an oleic acid-containing
Or, it relates to a method for producing oleic acid phospholipid and a new species of microorganism for producing the same.
(従来の技術)
生体の細胞膜を構成する脂質の種類及び脂肪酸組成は、
膜蛋白の親和性に大きな影響を及ぼし、その安定性や活
性に大きく寄与していることが細胞膜の研究から明らか
になりつつある。一方、生体の生理活性成分の研究から
、特に長鎖の飽和又は不飽和脂肪酸或いは直鎖又は分岐
脂肪酸の抗潰瘍作用や抗炎症作用が知られている。これ
ら脂肪酸の生理活性作用については不明な点が多いが、
遊離型かエステル型かによっても活性が異なることも報
告されている。このような脂肪酸を治療薬として使用す
るときは活性発現時の化学型だけではなく、投与時の吸
収効率や生体内での安定性も総合的な効果を左右する大
きな因子である。脂肪酸は生体内では遊離型やエステル
型で蓄積されることはなく、多くの場合生体膜としての
リン脂質や糖脂質或いは脂肪&II織におけるグリセラ
イドとして存在している。遊離脂肪酸や脂肪酸エステル
:よLl−ろ毒性か知るれでいる。従って、生理活性イ
1用を有する脂肪酸:二、1.脂質や糖脂質に巳た場合
、生体内コニわける安定性や吸収効率ニーおいて遊離型
やエステル型2こ優ることが考えられ、結果的に高い生
理活性が期待できる。(Prior art) The types of lipids and fatty acid composition that constitute the cell membranes of living organisms are
It is becoming clear from research on cell membranes that it has a major influence on the affinity of membrane proteins and contributes greatly to their stability and activity. On the other hand, from research on physiologically active components in living organisms, it has been known that long-chain saturated or unsaturated fatty acids, or straight-chain or branched fatty acids, in particular, have anti-ulcer and anti-inflammatory effects. Although there are many unknowns regarding the physiologically active effects of these fatty acids,
It has also been reported that the activity differs depending on whether it is in the free or ester form. When such fatty acids are used as therapeutic agents, not only the chemical type at the time of expression of activity, but also absorption efficiency upon administration and stability in the body are major factors that influence the overall efficacy. Fatty acids are not accumulated in free or ester forms in living organisms, and in many cases exist as phospholipids and glycolipids in biological membranes or glycerides in adipose tissue. Free fatty acids and fatty acid esters: Everyone knows how toxic they are. Therefore, fatty acids with physiological activity (1): 2, 1. When it comes to lipids and glycolipids, it is thought that they are superior to the free and ester forms in terms of in vivo stability and absorption efficiency, and as a result, high physiological activity can be expected.
現在入手可能な天然から得られるリン脂質:よ、アノル
基の脂肪酸組成を限定することは困難である。即ち、望
ましい脂肪酸以外の脂肪酸の存在下での効果しか期待で
きない。Currently available naturally occurring phospholipids: It is difficult to limit the fatty acid composition of the anol group. That is, the effect can only be expected in the presence of fatty acids other than the desired fatty acids.
(発明が解決しようとする課B)
長鎖脂肪酸が有する生理活性作用をより有効に利用する
或いは更に未知の生理活性作用を検定するために、及び
広い範囲で利用し得るために、脂肪酸を遊離型やエステ
ル型ではなく生体細胞膜の構成要素であるリン脂質は有
望な化学形である。(Problem B to be solved by the invention) In order to more effectively utilize the physiologically active effects of long-chain fatty acids, or to assay unknown physiologically active effects, and to be able to utilize them in a wide range, fatty acids are freed. Phospholipids, which are constituents of biological cell membranes rather than esters or esters, are a promising chemical form.
しかし、構成脂肪酸を限定する必要があり、現在のとこ
ろ化学合成に転らざるを得ないが大量に安価な生産が困
難であるにれらのことから、本発明は精製が容易で純度
の高いものが得られ、かつ培養時間が短く培養制御が容
易な微生物を利用した第一の構成脂肪酸を含f1する脂
質の生産方法を見い出すことにある。However, it is necessary to limit the constituent fatty acids, and at present we have no choice but to turn to chemical synthesis, which is difficult to produce in large quantities at low cost. The object of the present invention is to find a method for producing a lipid containing the first constituent fatty acid f1 using a microorganism that can be obtained in a short culture time and that is easy to control the culture.
(課邪を解決する1こめの手段)
本発明者らは、海洋の微生物の中にほぼオレイン酸のみ
を構成脂肪酸として含有する脂質を生産する新種の微生
物を見い出し、この知見二二基づいて本発明を完成した
。(One step to solving the problem) The present inventors discovered a new type of microorganism in the ocean that produces lipid containing almost only oleic acid as a constituent fatty acid, and based on this knowledge22, the present inventors Completed the invention.
従って、本発明はオレイン酸を高純度で含有する脂質を
生産することができる新種微生物を培養することによっ
て、オレイン酸含を脂質を生成せしめ、所望によりオレ
イン酸及び/又はオレイン酸リン脂質を単離することを
特徴とするオレイン酸含有脂質、オレイン酸及び/又は
オレイン酸リン脂質の製造方法並びにオレイン酸含有脂
質を生産することができる新種微生物を提供するもので
ある。Therefore, the present invention produces lipids containing oleic acid by culturing a new type of microorganism capable of producing lipids containing highly purified oleic acid, and optionally produces monophospholipids containing oleic acid and/or oleic acid. The present invention provides a method for producing oleic acid-containing lipids, oleic acid and/or oleic acid phospholipids, and a new species of microorganism capable of producing oleic acid-containing lipids.
(具体的な説明)
■ 微生物
本発明において使用する新種微生物は、オレイン酸又は
オレイン酸を含有する脂質を生産するこ止かできるもの
であり、このよう′i徽生物は自然界かみ新たに分離で
きる。(Specific explanation) ■ Microorganisms The new species of microorganisms used in the present invention are capable of producing oleic acid or lipids containing oleic acid, and such microorganisms can be newly isolated in nature. .
このような微生物の例として、5CRC−5゜07 (
微工研菌寄第1)671号)を挙げることができる。An example of such a microorganism is 5CRC-5゜07 (
1) No. 671).
前記の新菌株は次のようにして分離した。次の第1表に
示す組成の培地を調整した。The above new bacterial strain was isolated as follows. A culture medium having the composition shown in Table 1 below was prepared.
第1表
ペプトン 1 %酵母エキス
0.3%肉エキス
0.3%NaC13%
蒸留水 p H7,0この寒天平
板培地に南極海から採取した海水サンプルを滅菌した生
理食塩水で適度に希釈したものを接種し、25℃で1〜
2日間培養した。この寒天平板培地に出現したコロニー
を同し培地組成の斜面培地に釣菌した。Table 1 Peptone 1% Yeast Extract
0.3% meat extract
0.3% NaC 13% Distilled water pH 7.0 This agar plate medium was inoculated with a seawater sample collected from the Southern Ocean, moderately diluted with sterilized physiological saline, and incubated at 25°C for 1~
It was cultured for 2 days. Colonies that appeared on this agar plate medium were plated onto a slanted medium having the same medium composition.
このようにして海洋より採取した海水サンプルから多数
の菌株を分離した0次に第1表の培地より寒天をぬいた
ものを試験管に5 ずつ分圧し、同様に滅菌した。本新
菌種をこの培地で25゛Cで1〜2日間培養した。得ら
れた培養液より後記の方法によりオレイン酸産生能を検
定した。このようにして、オレイン酸を顕著に生産する
新菌種5CRC−8007を得た。この新菌種は次のよ
うな菌学的性質を有する。A large number of bacterial strains were thus isolated from the seawater samples collected from the ocean, and the agar was removed from the culture medium shown in Table 1, which was then placed under partial pressure of 5 parts in test tubes and sterilized in the same manner. The new bacterial species was cultured in this medium at 25°C for 1 to 2 days. The oleic acid production ability of the obtained culture solution was assayed by the method described below. In this way, a new bacterial strain 5CRC-8007 which significantly produces oleic acid was obtained. This new bacterial species has the following mycological properties.
観察項目 a)形態 l 細胞の形 大きさ 2 多形性の有無 3 運動性の有無 鞭毛の着生状態 4 胞子の有無 5 グラム染色 6 抗酸性 長かん菌 1、OX 4.0μm 無 有 一本、 8if[2毛 無 陰性 陰性 b’7@喧地に於ける生育状態 l 肉汁寒天平板培養(25°C イノコロニー形状(直径) C)コロニーの形 ハ)コロニー表面の形状 二)コロニーの隆起状態 ホ)コロニーの周縁 へ)コロニーの色調 ト)コロニーの透明度 チ)コロニーの光沢 す)可溶性色素の生成 2 肉汁寒天斜面培養(25℃。Observation items a) Form l Cell shape size 2 Presence or absence of polymorphism 3 Presence or absence of motility Epiphytic state of flagella 4 Presence or absence of spores 5 Gram staining 6 Anti-acidity Nagabu bacterium 1, OX 4.0μm Nothing Yes One, 8if [2 hairs] Nothing negative negative b’7@Growing conditions in a busy area l Meat juice agar plate culture (25°C Ino colony shape (diameter) C) Colony shape C) Shape of colony surface 2) Prominence of colony e) Colony periphery f) Colony color tone g) Colony transparency H) Colony gloss ) Generation of soluble pigments 2. Broth agar slant culture (25℃).
イ)生育の良否 口)コロニーの光沢 3 肉汁液体培地(25℃。b) Quality of growth mouth) Colony gloss 3. Meat juice liquid medium (25℃).
イ)表面の生育
口)濁度
ハ)沈澱
二)ガス発生
2日間)
2、 OX 2.4 m
円形
平滑
台状
金縁
淡黄色
不透明
鈍光
無
2日間)
良好
鈍光
2日間)
無
濁る
粉状
無
2日間ン
液化−な(
凝固二、九〇
4 肉汁セラ千し (25℃
ゼラ・(ン液化
5 リドマスミルク
C)生理学的性質
1 硝酸塩の還元
2 脱窒
MR
4■P
5 インドール生成
6 硫化水素の生成
7 デンプンの加水分解
8 クエン酸利用
イ)Koser
口)Christensen
9 硝酸塩の利用
10 色素生成
イ)King A 培地
口))(ing B 培地
1) ウレアーゼ
12 オキシダーゼ
13 カタラーゼ
14 生育の範囲
イ)pH
口)温度
15 M素に対する態度
160−Fテスト(グルコース)
17 $IRから酸及びガス生成
1、L−アラビノース
2、D−キシロース
3、D−グルコース
4、D−マンノース
5.0−フラクトース
6、D−ガラクトース
7、麦芽糖
8、ショ糖
9、乳糖
10゜トレハロース
1)、D−ソルビット
12、D−マンニット
13、イノシフト
6〜10
1℃〜35℃
好気性
14、グリセリン
15、デン′ブン
d)その他の諸性質
SS寒天培地での生育 十
マンコンキー寒天培地での生育
6.5%N a Cl耐塩性
DNa s e
オルニチンの分解
アルギニンの分解
ゼラチンの分解
G−C含量 44.2〜44.5上
記の菌学的性質に基づき、ハージイズ・マニュアル・オ
プ・ディターミナティブ・バクテリオロジー第8版、1
989年の分類基準に従って、本菌は新種の細菌である
と同定した。b) Growth opening on the surface) Turbidity C) Sedimentation 2) Gas generation 2 days) 2, OX 2.4 m Round, smooth platform-like gold edge Pale yellow opaque No dull light for 2 days) Good dull light for 2 days) Non-turbid powder No liquefaction for 2 days (Coagulation 2, 904 Meat Juice Sera Senshi (25℃ Gelatin (liquefaction 5 Ridmus Milk C) Physiological properties 1 Reduction of nitrate 2 Denitrification MR 4■P 5 Indole formation 6 Hydrogen sulfide Production of starch 7 Hydrolysis of starch 8 Utilization of citric acid a) Koser 9 Christensen 9 Utilization of nitrate 10 Pigment production a) King A Medium inlet)) (ing B Medium 1) Urease 12 Oxidase 13 Catalase 14 Growth range a) pH Mouth) Temperature 15 Attitude towards M elements 160-F test (glucose) 17 Acid and gas production from $IR 1, L-arabinose 2, D-xylose 3, D-glucose 4, D-mannose 5.0-fructose 6, D-galactose 7, maltose 8, sucrose 9, lactose 10° trehalose 1), D-sorbitol 12, D-mannitol 13, Innoshift 6-10 1°C-35°C Aerobic 14, Glycerin 15, Den'bun d ) Other properties Growth on SS agar medium Growth on Juman Conkey agar medium 6.5% Na Cl salt tolerance DNAse Decomposition of ornithine Decomposition of arginine Decomposition of gelatin G-C content 44.2-44.5 Based on the above mycological properties, Harsey's Manual of Determinative Bacteriology 8th Edition, 1
This bacterium was identified as a new species of bacterium according to the 989 classification criteria.
■ オレイン酸含有脂質、オレイン酸及びオレイン酸リ
ン脂質の製造方法
前記の微生物を培養して本発明のオレイン酸を製造りよ
うとする場合、基礎栄養培地とじ一ニーの発明の微生物
か増殖″7得るものであればいずれを使用しても、−(
・。この培地は、窒素源とl−て例えば酵母エキス、ペ
プトン、肉エキスなとの1種類または複数を含有する。■ Method for producing oleic acid-containing lipids, oleic acid, and oleic acid phospholipids When attempting to produce the oleic acid of the present invention by culturing the above-mentioned microorganisms, the microorganisms of the invention of Jichiney are grown in a basal nutrient medium.''7 Use whatever you get, −(
・. The medium contains a nitrogen source and one or more of, for example, yeast extract, peptone, meat extract.
又、この培地には1・要に応して炭素源として各種の糖
類を加えることかできる。この培地には塩化ナトリウム
、もしくは天然海水や人工海水を加えることが好ましい
。培養は固体培地又は液体培地のいずれを用いて行って
もよいが、目的とするオレイン酸を多量に得るためには
液体培地を用い、静置培養もしくは振盪培養、通気・攪
拌培養により好気的条件下で培養を行うのが好ましい。In addition, various sugars can be added to this medium as a carbon source as required. It is preferable to add sodium chloride, natural seawater, or artificial seawater to this medium. Cultivation may be carried out using either a solid medium or a liquid medium, but in order to obtain a large amount of the desired oleic acid, a liquid medium is used, and aerobic culture is performed using static culture, shaking culture, or aeration/agitation culture. It is preferable to carry out the culturing under these conditions.
培養温度は菌が生育し、オレイン酸が生産される温度範
囲であればいずれの温度でも良く、好ましくは1〜35
℃である。pHは6〜10の範囲である。培養時間は採
取し得る量のオレイン酸含有脂質が生産される時間を選
べば良く、好ましくは10〜120時間である。The culture temperature may be any temperature within the temperature range at which bacteria grow and oleic acid is produced, preferably from 1 to 35
It is ℃. The pH ranges from 6 to 10. The culture time may be selected such that a collectable amount of oleic acid-containing lipid is produced, and is preferably 10 to 120 hours.
次に得られた培養物から本発明のオレイン酸が採取され
る。精製法として通常の脂質精製法を用いる二とができ
る。例えば、t8養液から遠、L・分離濾過なとの常用
の集菌手段二こよっ−こ菌体を集める。Next, the oleic acid of the present invention is collected from the resulting culture. As a purification method, a conventional lipid purification method can be used. For example, two bacterial cells can be collected from a T8 nutrient solution using conventional bacterial collection methods such as L-separation filtration.
次に二の菌体を所望により水、食塩水、又は級!■液、
例えばリン酸緩衝液などにより洗浄した後、これらの液
中に再?、 濁する。この懸/gJ/fi、を脂質の抽
出のために常用されている溶剤、例えばクロロホルム/
メタノール混合物により抽出し、相分路してクロロホル
ム相を得る。次に、このクロロホルム相を蒸発除去する
ことによりオレイン酸含有脂質を含む材料が得られる。Next, add the second bacterial cell to water, saline, or water as desired. ■Liquid,
For example, after washing with phosphate buffer, etc., re-inject into these solutions. , become cloudy. This suspension/gJ/fi is converted into a solvent commonly used for lipid extraction, such as chloroform/gJ/fi.
Extract with a methanol mixture and phase split to obtain a chloroform phase. Next, the chloroform phase is removed by evaporation to obtain a material containing an oleic acid-containing lipid.
常法によりこれをけん化することにより遊離のオレイン
酸又はその塩を得ることができる。Free oleic acid or its salt can be obtained by saponifying it by a conventional method.
オレイン酸リン脂質はオレイン酸含有脂質をアセトン沈
澱により処理することにより製造することができる。Oleic acid phospholipids can be produced by treating oleic acid-containing lipids by acetone precipitation.
かくして本発明は上記の細菌を使用することにより、精
製が容易でかつ短時間で多量にオレイン酸含有脂質、オ
レイン酸及び/又はオレイン酸リン脂質を得ることがで
きる。Thus, by using the above-mentioned bacteria, the present invention can easily purify and obtain a large amount of oleic acid-containing lipids, oleic acid and/or oleic acid phospholipids in a short period of time.
次に本発明の具体的な実施例を示す。Next, specific examples of the present invention will be shown.
実施例1.5cRc−soo7からのオレイン酸含有M
ri質の生産
ペプトン1%、酵母エキス0.3%、肉エキス03%、
NaC14,5%を含有し、pH7,0に調整した培地
100 t−15分間加姑殺菌した後、5CRC−8
007を接種し、25℃で12時間好気的に培養した。Oleic acid-containing M from Example 1.5cRc-soo7
1% production peptone, 0.3% yeast extract, 03% meat extract,
After sterilizing the medium containing 14.5% NaC and adjusting the pH to 7.0 for 15 minutes, 5CRC-8
007 was inoculated and cultured aerobically at 25°C for 12 hours.
培養後、遠心分剤機で菌体を採取し、乾燥重量約160
■の菌体を得た。菌体を1/2濃度の人工海水で1回洗
浄した後、10の1/2濃度の人工海水に懸濁した。こ
の菌体懸濁液をlOのクロロホルム/メタノール溶液(
2: I v/v)で良く振盪抽出した後、遠心分離し
、クロロホルム相を得た。更に、同し溶液で2回抽出し
、クロロホルム相をまとめ抽出画分を濃縮乾固して得ら
れた脂質画分は6■(乾燥菌体当り3.8%)であった
。この脂質画分にはオレイン酸が含まれる。この脂質画
分を8%塩酸メタノールで80℃、1時間加熱し、メチ
ルエステル化した後、ガスクロマトグラフにて分析した
ところ、4.3■のオレイン酸が含まれていることがね
かつた。なお、総脂肪酸中におけるオレイン酸の割合は
90,5%であった。After culturing, the bacterial cells were collected using a centrifugal dispensing machine, and the dry weight was approximately 160.
■ Bacterial cells were obtained. After washing the bacterial cells once with 1/2 concentration artificial seawater, they were suspended in 10 1/2 concentration artificial seawater. This bacterial cell suspension was mixed with lO chloroform/methanol solution (
2:I v/v) and then centrifuged to obtain a chloroform phase. Furthermore, the same solution was extracted twice, the chloroform phase was combined, and the extracted fractions were concentrated to dryness. The lipid fraction obtained was 6.5 (3.8% per dry bacterial cell). This lipid fraction contains oleic acid. This lipid fraction was heated with 8% hydrochloric acid and methanol at 80° C. for 1 hour to methyl esterify it, and then analyzed by gas chromatography, and it was found that it contained 4.3 μ of oleic acid. Note that the proportion of oleic acid in the total fatty acids was 90.5%.
実施例2.5CRC−5007からのオレイン酸リン脂
質の生産
ペプトン1%、酵母エキス0.3%、肉エキス0.3%
、NaCl3%を含有し、pH7,0に調整した培地1
)を15分間加熱滅菌した後、5CRC−3OO7を接
種し、25℃で12時間好気的に培養した。培養後、遠
心分離機で菌体を採取し、湿重蓋で約12gの菌体を得
た。この菌体をJ/2濃度の人工海水で1回洗浄した後
、100 の1/2濃度の人工海水に懸濁した。この
菌体235液を100 のクロロホルム/メタノール溶
液(2: 1 v/v)で良く振盪抽出した後、遠心分
離し、クロロホルム相を得た。更に、同し溶液で2回抽
出し、クロロホルム相をまとめ、減圧!縮した。この濃
縮液を冷アセトン50 に加え、リン脂質は沈澱画分と
して得た。上清は濾過法で除去! 濾紙上に残ったリン
脂質の沈澱をクロロホルムで溶出後、クロロホルムを減
圧除去して約60■のリン脂質を得1こ。このリン脂質
の脂肪酸組成を実施例1、と同様↓こガスクロマトグラ
フで分析したところ、約42■のオレイン酸が含まれて
いた。なお、総脂肪酸中ニーおけるオレイン酸の割合は
88.7%であった。Example 2.5 Production of oleic acid phospholipids from CRC-5007 Peptone 1%, yeast extract 0.3%, meat extract 0.3%
, medium 1 containing 3% NaCl and adjusted to pH 7.0
) was heat sterilized for 15 minutes, then inoculated with 5CRC-3OO7 and cultured aerobically at 25°C for 12 hours. After culturing, the bacterial cells were collected using a centrifuge, and about 12 g of bacterial cells were obtained using a wet heavy lid. The cells were washed once with artificial seawater of J/2 concentration and then suspended in artificial seawater of 1/2 concentration of 100. The 235 bacterial cells were extracted by shaking thoroughly with a 100% chloroform/methanol solution (2:1 v/v), and then centrifuged to obtain a chloroform phase. Furthermore, extract twice with the same solution, combine the chloroform phases, and reduce the pressure! Shrunk. This concentrated solution was added to 50 ml of cold acetone to obtain phospholipids as a precipitated fraction. Remove the supernatant by filtration! After eluting the phospholipid precipitate remaining on the filter paper with chloroform, the chloroform was removed under reduced pressure to obtain about 60 μg of phospholipid. The fatty acid composition of this phospholipid was analyzed by gas chromatography in the same manner as in Example 1, and it was found that it contained about 42 oleic acid. The proportion of oleic acid in the total fatty acids was 88.7%.
手続ン甫正書(自発) 平成3年7月l1日 特許子長官 深沢 亘殿 1、事件の表示 平成2年特許願第224434号 2、発明の名称Procedural text (spontaneous) July 1, 1991 Director General of Patent Persons Wataru Fukasawa 1.Display of the incident 1990 Patent Application No. 224434 2. Name of the invention
Claims (3)
物を培養することによってオレイン酸含有脂質を生成せ
しめることを特徴とする、オレイン酸含有脂質の製造方
法。(1) A method for producing an oleic acid-containing lipid, which comprises producing an oleic acid-containing lipid by culturing a microorganism capable of producing an oleic acid-containing lipid.
イン酸及び/又はオレイン酸リン脂質を単離することか
ら成る、オレイン酸及び/又はオレイン酸リン脂質の製
造方法。(2) A method for producing oleic acid and/or oleic acid phospholipid, which comprises isolating oleic acid and/or oleic acid phospholipid from the oleic acid-containing lipid according to claim (1).
物であるSCRC−S007。(3) SCRC-S007, a microorganism capable of producing oleic acid-containing lipids.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2224434A JPH04108393A (en) | 1990-08-28 | 1990-08-28 | Production of oleic acid-containing lipid and microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2224434A JPH04108393A (en) | 1990-08-28 | 1990-08-28 | Production of oleic acid-containing lipid and microorganism |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04108393A true JPH04108393A (en) | 1992-04-09 |
Family
ID=16813717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2224434A Pending JPH04108393A (en) | 1990-08-28 | 1990-08-28 | Production of oleic acid-containing lipid and microorganism |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04108393A (en) |
-
1990
- 1990-08-28 JP JP2224434A patent/JPH04108393A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3789435T2 (en) | Process for the preparation of eicosapentaenoic acid. | |
JPH0670754A (en) | Biotechnological preparation of pseudomonas aeruginosa and l-rhamnose and use thereof | |
Cooper et al. | Enzyme formation and polysaccharide synthesis by bacteria: Polysaccharides produced by “nitrogen-fixing” organisms | |
FI70924C (en) | FOERFARANDE FOER FRAMSTAELLNING AV ENZYMEN KOLESTERAS | |
WO2021056683A1 (en) | Strain for producing lipase and application thereof | |
JPH06500004A (en) | Production of protein compositions | |
JPH04108393A (en) | Production of oleic acid-containing lipid and microorganism | |
JPS6314697A (en) | Production of eicosapentaenoic acid | |
JP2698052B2 (en) | Eicosapentaenoic acid-producing microorganism | |
JPS63216490A (en) | Production of eicosapentaenoic acid by microorganism and microorganism using therefor | |
DE2363285B2 (en) | Process for the production of 1-malic acid from fumaric acid | |
JPH0722513B2 (en) | Bishomo-γ-linolenic acid and method for producing lipid containing the same | |
JP2898022B2 (en) | Method for producing collagen degrading enzyme | |
JPS63202392A (en) | Production of unsaturated fatty acid and derivative thereof | |
JPH0763381B2 (en) | Method for producing lipid containing eicosapentaenoic acid by microorganism | |
JPH012587A (en) | Method for producing eicosapentaenoic acid-containing lipid using microorganisms | |
JPH0763380B2 (en) | Method for producing eicosapentaenoic acid-containing lipid by microorganism | |
SU763463A1 (en) | Method of preparing dehydrogenases | |
SU1632974A1 (en) | Strain of bacteria proteus vulgaris - producer of restrictase pvull | |
JPH0378106B2 (en) | ||
JP4752024B2 (en) | Cell wall degrading enzyme, producing microorganism, and protoplast preparation method using the same | |
JPS6356294A (en) | Production of carnitine | |
SU759055A3 (en) | Method of biomass production | |
JPH0260313B2 (en) | ||
JPS60114188A (en) | Novel bacterium |